Partner with us to showcase your brand and capitalize on our audience of leading companies with active pipelines in HBV.
The 2nd Chronic HBV Drug Development Summit is your opportunity to position your brand at the forefront of the minds of highly engaged experts in virology and hepatology. Partner with us to showcase your brand and capitalize on our audience of leading companies with active pipelines in HBV.
As cross-company industry partnerships forging synergistic combination regimens herald a new era of drug development for direct antiviral and immunotherapy pipelines, pivotal advances in translational tools including predictive animal models and viral antigen assays are redefining the landscape of HBV drug development.
We understand each business is different, so we will work with you to build a bespoke package to fulfil your business objectives and elevate your company’s influence.
Secure an exhibition booth
to present and position your capabilities to developers who are actively seeking new solutions to optimize drug development inefficiencies
with stakeholders during our coordinated networking sessions to first-hand understand their requirements and present your solution
Deliver a presentation
and influence the thinking of translational and pre-clinical decision makers working to identify new promising compounds